Clinical Trials Logo

Filter by:
NCT ID: NCT01155505 Active, not recruiting - Clinical trials for Advanced Solid Tumors

Lenalidomide and Paclitaxel in Advanced Solid Tumors

Start date: November 2009
Phase: Phase 1
Study type: Interventional

This is a dose finding, open-label, uncontrolled, dose-escalation trial to determine the maximum Tolerated Dose (MTD) of the combination of CC-5013 (Lenalidomide)and paclitaxel in patients with advanced solid tumors. Other purposes of the study are: 1. Define the safety profile of the CC-5013 and paclitaxel given in combination 2. Define the pharmacokinetics of CC-5013 and paclitaxel given in combination 3. Define the pharmacodynamic effects of the combination by monitoring potential biomarkers of the different biological activities of each component of the regimen 4. Define the optimal biological dose (OBD) and the dose recommended (RD) for phase II studies in selected tumor types (breast, ovary, prostate, NSCLC) 5. Collect evidence of antitumor activity in selected tumor types

NCT ID: NCT01148628 Active, not recruiting - Clinical trials for Advanced Solid Tumors

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Start date: October 2007
Phase: Phase 1
Study type: Interventional

This is a dose finding, open-label, uncontrolled, dose-escalation trial to determine the Maximum Tolerated Dose (MTD) and the Recommended Dose (RD) of the combination RAD001 (escalating daily dose) and CaelyxTM (fixed dose) to patients with advanced solid tumors. Other purposes of the study are: 1. define the safety profile of the combination after repeated administrations 2. define hints of antitumor activity, to be confirmed in subsequent disease-oriented expansion phases at the RD. 3. define the pharmacokinetic profile of the combination

NCT ID: NCT01107340 Active, not recruiting - Osteoarthritis Clinical Trials

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

Start date: January 2010
Phase: N/A
Study type: Interventional

This is a multicentre post-marketing prospective study to evaluate performance and clinical outcomes of AMIIStem primary hip system.

NCT ID: NCT01101425 Active, not recruiting - Breast Cancer Clinical Trials

Male Breast Cancer: Understanding the Biology for Improved Patient Care

Start date: December 2010
Phase:
Study type: Observational [Patient Registry]

Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease. Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010. Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014).

NCT ID: NCT01097967 Active, not recruiting - Ischemic Stroke Clinical Trials

Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy

SAS-CARE
Start date: July 2010
Phase: Phase 4
Study type: Interventional

The study aims to observe the short term effect (3-month) of sleep disordered breathing (SDB) on cardiovascular parameters, heart rate variability, endothelial function and surrogate markers of atherosclerosis after acute cerebrovascular events (ACE). The long-term effect (6-24-month) of Continuous Positive Airway Pressure (CPAP) on clinical vascular outcome, cardiovascular parameters, evolution of surrogate of atherosclerosis heart rate variability and endothelial function after ACE is observed over 24 months. A preventive effect of CPAP therapy on cerebro-vascular events in patients with moderate-severe obstructive SDB without sleepiness after ictus or transient ischaemic attack will be evaluated.

NCT ID: NCT01082367 Active, not recruiting - Clinical trials for Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

EARLY
Start date: April 2010
Phase: Phase 3
Study type: Interventional

This study will investigate the efficacy of inhaled TOBI treatment for early infections of P. aeruginosa in paediatric patients with cystic fibrosis.

NCT ID: NCT01065454 Active, not recruiting - Clinical trials for Hypertension, Pulmonary

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

LEPHT
Start date: April 14, 2010
Phase: Phase 2
Study type: Interventional

The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ventricular systolic dysfunction

NCT ID: NCT01042470 Active, not recruiting - Clinical trials for Pelvic Organ Prolapse

Pelvic Floor Study: Biomechanical Properties of the Female Pelvic Floor

Start date: January 2010
Phase:
Study type: Observational

Pelvic floor dysfunction in the form of pelvic organ prolapse or urinary and fecal incontinence is a sequela for some women who experience injuries during birth. It affects adult women of all ages. The life time risk for women by age of 80 years for undergoing surgical correction is shown to be 11.1 % , and 29 % of them will undergo re-operation for recurrences later on. Still, even today the biomechanics of the pelvic floor is not understood enough. The aim of our study is to investigate the biomechanical properties of the female pelvic floor, i.e. the vaginal wall, by means of clinical, sonomorphometric (ultrasound), histological and elastomechanical examinations. In principle, the elasto-mechanical properties of the vaginal wall will be examined by the new and innovative so called aspiration device, developed at the Eidgenoessische Technische Hochschule (ETH) Zurich, Switzerland. This tool generates a low-pressure of -25 mbar at the vaginal wall, aspirating it under visual control by aid of an integrated video camera and therefore allowing to measure the difference of its convexity under aspiration and at rest. In case of prolapse surgery, this allows us to take a biopsy of the measured vaginal wall and analyze it at the Institute of Anatomy at the University of Zurich-Irchel by means of histological (e.g. connective tissue, extracellular matrix) and molecular biological examination. With an increasing elderly population, more and more women will need surgery for pelvic organ prolapse. While effective in restoring anatomy, sometimes by aid of meshes made out of polypropylene, the functional outcomes and quality of life are not always restored satisfactorily. This interdisciplinary project intends to add a contribution to this for our patient still bothersome situation and to help to detect risk factors for developing pelvic floor dysfunction.

NCT ID: NCT01025297 Active, not recruiting - Hepatitis C Clinical Trials

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone

Eclipse 2
Start date: July 2008
Phase: Phase 1/Phase 2
Study type: Interventional

This study is designed to evaluate the safety of biological active dose of a new experimental drug, IL-7, in combination with standard bi-therapy in patients with Hepatitis C chronic infection identified as non responders to the standard bi-therapy alone.

NCT ID: NCT01012856 Active, not recruiting - Unipolar Depression Clinical Trials

Randomized Clinical Trial of an Exposure-based Cognitive Therapy for Depression

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate, if exposure-based cognitive therapy (EBCT) is at least as effective as the established cognitive-behavioral therapy and more effective in its long-term efficacy. Moreover the mechanisms of change of the EBCT are investigated.